References
- Meunier F. Candidiasis. Eur J Clin Microbiol Infect Dis 1989; 8 (5):438–447.
- Dodd CL, Greenspan D, Ketz MH, Westenhouse JL, Feigal DW, Greenspan JL. Oral candidiasis in HIV infection: pseudomembranous and erythematous candidiasis show similar rates of progression to AIDS. AIDS 1991; 5(11): 1339–1343.
- Podzamcler D, Casanova A, Santamaria P, Benasco C, Gudil F. Esophageal candidiasis in the diagnosis of HIV-infected patients. JAMA 1988; 259 (9): 1328–1329.
- De Vries-Hospers GH, Van Der Waaji D. Salivary concentrations of amphotericin B following its use as an oral lozenge. Infection 1980; 8: 63–65.
- Dismukes EW. Azole antifungal drugs: old and new. Ann Intern Med 1988; 109 (3): 177–179.
- Shaunak S, Cohen J. Clinical management of fungal infection in patients with AIDS. J Antimicrob Chemother 1991; 28 (Suppl. A): S67-S82.
- Galgiani JN. Fluconazole, a new antifungal agent. Ann Intern Med 1990; 113 (3): 177–181.
- Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Morb Mort Wkly Rep 1987; 36 (Suppl. IS): 3S-15S.
- Cooper BH, Silva-Hutner M. Yeasts of medical importance. In: Lennette EH, Baboa A, Hausler WJ, Shadomy NJ, eds. Manual of Clinical Microbiology. Washington DC 1985: 526–541.
- Gordon MA, Lapa WE, Passero GP. Improved method for azole antifungal susceptibility testing. J Clin Microbiol 1988; 26 (9): 1874–1877.
- Arzeni D, Barchiesi F, Ancarani F, Scalise G. Fluconazole, itraconazole and ketoconazole in vitro activity. A com-parative study. J Chemother 1991; 3 (3): 139–142.
- Diamond RD. The growing problem of mycoses in patients infected with the human immunodeficiency virus. Rev Infect Dis 1991; 13: 480–486.
- Gould E, Kory WP, Raskin JB, Ibe MJ, Redlhammer DE. Esophageal biopsy findings in the acquired immunodeficiency syndrome (AIDS): clinicopathologic correlation in 20 patients. South Med J 1988; 81: 1392–1395.
- Hay RJ. Antifungal therapy and the new azole compounds. J Antimicrob Chemother 1991; 28 (Suppl. A): S35-S46.
- Willocks L, Leen CLS, Brettle RP, Urquhart D, Russell TB, Milne LJR. Fluconazole resistance in AIDS patients. JAC 1991; 28 (6): 937–939.
- Hitchcock CA, Barrett-Bee KJ, Russell NJ. The lipid composition of azole-sensitive and azole-resistant strains of Candida albicans. J Gen Microbiol 1986; 132: 2421–2431.
- Hitchcock CA, Barrett-Bee KJ, Russell NJ. The lipid composition and permeability to azole of an azole- and polyene-resistant mutant of Candida albicans. J Med Vet Mycol 1987; 25: 29–37.
- Ryley JF, Wilson RG, Barrett-Bee KJ. Azole resistance in Candida albicans. Sabouraudia 1984; 22: 53–63.
- Mcllroy MA. Failure of fluconazole to suppress fungemia in a patient with fever, neutropenia, and typhlitis. J Infect Dis 1991; 163: 420–421.
- Warnock DW, Burke J, Cope NJ, Johnson EM, von Fraunhofer NA, Williams EW. Fluconazole resistance in Candida glabrata. Lancet 1988; 2: 1310.
- Meunier F, Aoun M, Gerard M. Therapy for oropharyngeal candidiasis in the immunocompromised host: a randomized double-blind study of fluconazole vs. ketoconazole. Rev Infect Dis 1990; 12 (Suppl. 3): S364-S368.
- Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Sarai R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991; 325: 1274–1277.
- Shadomy S, Spinel-Ingroff A, Cartwright JR. Laboratory studies with antifungal agents: susceptibility tests and bioassay. In: Lennette EH, Baboa A, Hausler WJ, Shadomy NJ, eds. Manual of Clinical Microbiology. Washington DC 1985: 991–999.